Your browser doesn't support javascript.
loading
Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials.
Ferreira, João Pedro; Cleland, John G; Girerd, Nicolas; Rossignol, Patrick; Pellicori, Pierpaolo; Cosmi, Franco; Mariottoni, Beatrice; González, Arantxa; Diez, Javier; Solomon, Scott D; Claggett, Brian; Pfeffer, Marc A; Pitt, Bertram; Petutschnigg, Johannes; Pieske, Burkert; Edelmann, Frank; Zannad, Faiez.
Afiliação
  • Ferreira JP; Cardiovascular R&D Centre - UnIC@RISE, Department of Physiology and Cardiothoracic Surgery, Faculty of Medicine of the University of Porto, Porto, Portugal & Internal Medicine Departament, Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal; Université de Lorraine, In
  • Cleland JG; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
  • Girerd N; Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
  • Rossignol P; Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
  • Pellicori P; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
  • Cosmi F; Department of Cardiology, Cortona Hospital, Arezzo, Italy.
  • Mariottoni B; Department of Cardiology, Cortona Hospital, Arezzo, Italy.
  • González A; Program of Cardiovascular Diseases, CIMA, Universidad de Navarra and IdiSNA, Pamplona, Spain; CIBERCV, Carlos III Institute of Health, Madrid, Spain.
  • Diez J; Program of Cardiovascular Diseases, CIMA, Universidad de Navarra and IdiSNA, Pamplona, Spain; CIBERCV, Carlos III Institute of Health, Madrid, Spain.
  • Solomon SD; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Claggett B; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Pfeffer MA; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Pitt B; Division of Cardiology, University of Michigan, Ann Arbor, MI, USA.
  • Petutschnigg J; Department of Internal Medicine and Cardiology, Campus Virchow Klinikum, Charité University Medicine Berlin, Berlin, Germany; German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.
  • Pieske B; Department of Internal Medicine and Cardiology, Campus Virchow Klinikum, Charité University Medicine Berlin, Berlin, Germany; German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.
  • Edelmann F; Department of Internal Medicine and Cardiology, Campus Virchow Klinikum, Charité University Medicine Berlin, Berlin, Germany; German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.
  • Zannad F; Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
Int J Cardiol ; 377: 86-88, 2023 04 15.
Article em En | MEDLINE | ID: mdl-36738846

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espironolactona / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Int J Cardiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Índia País de publicação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espironolactona / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Int J Cardiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Índia País de publicação: Holanda